Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4(+)CD25(+)Foxp3(+) T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis
- PMID: 20403730
- DOI: 10.1016/j.clim.2010.03.006
Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4(+)CD25(+)Foxp3(+) T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis
Abstract
We investigate the frequencies of CD4(+)CD25(+)Foxp3(+) T cells and allergen-specific IL-10(+)IL-4(-), IFN-gamma(+)IL-4(-), IL-4(+)IFN-gamma(-)CD4(+) T cells (which display characteristics of nTreg, Tr1-, Th1- and Th2- cells, respectively) in peripheral blood mononuclear cells (PBMCs) of patients with AR and of healthy individuals. In addition, we estimated the suppressive effect of CD4(+)CD25(+) Treg cells and allergen-specific, IL-10-secreting cells from both two groups. The frequency of CD4(+)CD25(+)Foxp3(+) T cells is similar in 43 AR patients compared with 38 healthy subjects. CD4(+)CD25(high) cells retain suppressive activity on allergen-stimulated cell proliferation and cytokine production of Th1 but not Th2 cells in both groups. However, the frequency of allergen-specific IL-10(+)IL-4(-)CD4(+) T cells is reduced in AR patients, and correlates inversely to clinical symptom scores. Allergen-specific, IL-10-secreting cells potently suppressed D. pteronyssinus major allergen 1-stimulated cell proliferation and cytokine production (IFN-gamma and IL-4) in healthy individuals. Altogether our data indicate that the number and function of CD4(+)CD25(+) Treg cells from allergic patients are not impaired. However, the deficiency of allergen-specific Tr1 cells may play a role in the development of AR.
Similar articles
-
Responses of CD4(+) CD25(+) Foxp3(+) and IL-10-secreting type I T regulatory cells to cluster-specific immunotherapy for allergic rhinitis in children.Pediatr Allergy Immunol. 2012 Mar;23(2):140-9. doi: 10.1111/j.1399-3038.2011.01249.x. Epub 2011 Dec 23. Pediatr Allergy Immunol. 2012. PMID: 22192331 Clinical Trial.
-
Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.Int Arch Allergy Immunol. 2009;148(3):199-210. doi: 10.1159/000161580. Epub 2008 Oct 10. Int Arch Allergy Immunol. 2009. PMID: 18849611
-
A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis.Laryngoscope. 2007 May;117(5):876-80. doi: 10.1097/MLG.0b013e318033f99a. Laryngoscope. 2007. PMID: 17473687
-
Alloantigen specific T regulatory cells in transplant tolerance.Int Immunopharmacol. 2009 May;9(5):570-4. doi: 10.1016/j.intimp.2009.01.016. Epub 2009 Jan 29. Int Immunopharmacol. 2009. PMID: 19539571 Review.
-
Mechanisms of subcutaneous allergen immunotherapy.Immunol Allergy Clin North Am. 2011 May;31(2):175-90, vii-viii. doi: 10.1016/j.iac.2011.02.006. Immunol Allergy Clin North Am. 2011. PMID: 21530813 Review.
Cited by
-
Mechanisms of allergen-specific immunotherapy.Clin Transl Allergy. 2012 Jan 5;2(1):2. doi: 10.1186/2045-7022-2-2. Clin Transl Allergy. 2012. PMID: 22409879 Free PMC article.
-
Induced pluripotent stem cell-derived mesenchymal stem cells activate quiescent T cells and elevate regulatory T cell response via NF-κB in allergic rhinitis patients.Stem Cell Res Ther. 2018 Jun 19;9(1):170. doi: 10.1186/s13287-018-0896-z. Stem Cell Res Ther. 2018. PMID: 29921316 Free PMC article.
-
A significant increase in expression of FOXP3 and IL-17 genes in patients with allergic rhinitis underwent accelerated rush immunotherapy.Iran J Basic Med Sci. 2019 Sep;22(9):989-996. doi: 10.22038/ijbms.2019.32979.7878. Iran J Basic Med Sci. 2019. PMID: 31807241 Free PMC article.
-
Engineering nanoparticle therapeutics for food allergy.J Allergy Clin Immunol. 2024 Mar;153(3):549-559. doi: 10.1016/j.jaci.2023.10.013. Epub 2023 Nov 4. J Allergy Clin Immunol. 2024. PMID: 37926124 Free PMC article. Review.
-
Utility and Comparative Efficacy of Recombinant Allergens Versus Allergen Extract.Curr Allergy Asthma Rep. 2017 Aug 18;17(9):63. doi: 10.1007/s11882-017-0727-9. Curr Allergy Asthma Rep. 2017. PMID: 28822054 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials